Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Blastic-Plasmacytoid-Dendritic-Cell-Neoplasm"

1 News Found

AbbVie seeks FDA approval for Pivekimab Sunirine to treat rare, aggressive blood cancer
Drug Approval | October 01, 2025

AbbVie seeks FDA approval for Pivekimab Sunirine to treat rare, aggressive blood cancer

BPDCN is a challenging blood cancer with characteristics of both leukemia and lymphoma